PHI with atrioventricular septal defect (AVSD)
How does this condition affect your private health insurance?
Atrioventricular Septal Defect (AVSD), also known as endocardial cushion defect (which is what Ventrikelvorhofseptumdefekt refers to), is a complex congenital heart malformation where the central part of the heart fails to develop properly. This results in a common atrioventricular valve and an opening between the atria and ventricles, allowing oxygen-rich and oxygen-poor blood to mix. The severity varies; complete AVSD involves large defects in both the atrial and ventricular septa and a single, common AV valve, leading to significant blood shunting and increased blood flow to the lungs. This often causes heart failure symptoms in infancy, requiring surgical intervention. Without treatment, it can lead to pulmonary hypertension and severe complications.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Present from birth, with symptoms often manifesting within weeks or months of infancy.
Duration of Illness (Lifetime)
Chronic and progressive if untreated; potentially cured with surgical repair, but often requiring lifelong follow-up and management of potential long-term complications.
Cost of Treatment (Initial)
Very high (major open-heart surgery, extensive intensive care, potentially several hundred thousand USD).
Cost of Treatment (Lifetime)
High (initial surgery, potential re-interventions, lifelong monitoring, and medication for complications such as arrhythmias or pulmonary hypertension).
Mortality Rate
High (up to 80-90% by age 2-3 years without surgical intervention); significantly reduced to low (<5-10%) with successful surgical repair.
Risk of Secondary Damages
High (pulmonary hypertension, heart failure, arrhythmias, residual valve regurgitation, and increased risk of endocarditis).
Probability of Full Recovery
Moderate (surgical repair is generally effective, but lifelong monitoring for residual issues, valve dysfunction, or arrhythmias is often necessary; true 'recovery without any consequences' is not always guaranteed).
Underlying Disease Risk
High, especially Down syndrome (Trisomy 21), which is present in 50-70% of AVSD cases; other genetic syndromes may also be associated.